tradingkey.logo

Intuitive Surgical Inc

ISRG
View Detailed Chart
534.500USD
+4.480+0.85%
Close 10/31, 16:00ETQuotes delayed by 15 min
189.69BMarket Cap
69.06P/E TTM

Intuitive Surgical Inc

534.500
+4.480+0.85%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.85%

5 Days

-3.05%

1 Month

+19.51%

6 Months

+3.63%

Year to Date

+2.40%

1 Year

+4.03%

View Detailed Chart

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Intuitive Surgical Inc's Score

Industry at a Glance

Industry Ranking
11 / 210
Overall Ranking
56 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 35 analysts
Buy
Current Rating
598.118
Target Price
+11.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Intuitive Surgical Inc Highlights

StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 34.23% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.35B.
Undervalued
The company’s latest PE is 68.92, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 317.45M shares, decreasing 1.33% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 240.49K shares of this stock.

Financial Indicators

EPS

No Data

Total revenue

No Data

Intuitive Surgical Inc Info

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
Ticker SymbolISRG
CompanyIntuitive Surgical Inc
CEOMr. David J. Rosa
Websitehttps://www.intuitive.com/en-us/about-us/company
KeyAI